Zephyr AI

Zephyr AI has developed a proprietary machine learning-driven data analytics platform that leverages one of the world’s largest real-world clinicogenomic datasets. The company’s technology enables advanced predictive modeling, risk stratification, cohort construction, companion diagnostics development, and real-world evidence generation. It focuses on supporting pharmaceutical companies in drug development decision-making—especially in oncology and cardiometabolic disease—by providing actionable insights for patient selection and response prediction. The company has demonstrated empirical success navigating complex real-world patient data using explainable representation learning approaches.